The short answer
A specific toxic interaction between SAMe and perphenazine has not been established. Discuss SAMe with the psychiatric prescriber because a small schizophrenia trial reported both possible benefits and increased irritability in some participants.
What this answer covers
Oral perphenazine with the exact supplement preparation described.
- Supplement or preparation
- S-Adenosylmethionine
- Medication ingredient
- perphenazine
The small clinical trial had mixed results
Eighteen people with chronic schizophrenia and a selected COMT profile received SAMe or placebo as adjunctive treatment. Some aggression and quality-of-life measures improved, but two SAMe recipients had increased irritability.
It does not establish this exact drug combination
The inspected abstract does not resolve perphenazine-specific exposure or outcomes. Its result should not be described as either proof of a perphenazine toxicity interaction or assurance that SAMe is appropriate for every patient.
Keep psychiatric and serotonin warnings distinct
General SAMe guidance warns about mood worsening in bipolar disorder and possible interactions with serotonergic medicines. That does not automatically classify perphenazine as a serotonergic antidepressant or establish serotonin syndrome from this pair.
Plan changes with the treating clinician
Discuss why you want SAMe and monitor any new irritability or other symptom change with the prescriber. Do not substitute the supplement for perphenazine or change the prescription in response to a predicted interaction.
Evidence and practical considerations
Side effects & toxicity
A specific toxic interaction between SAMe and perphenazine has not been established. Discuss SAMe with the psychiatric prescriber because a small schizophrenia trial reported both possible benefits and increased irritability in some participants.
- Exact scope
- Oral perphenazine with the exact supplement preparation described. with Oral perphenazine with the stated label and formulation limits.
- Medication form and route
- oral
What remains uncertain
- Selected small COMT pilot has two irritability exacerbations and some benefit; no exact perphenazine allocation in inspected abstract. No invented serotonin syndrome or trial termination from inaccessible source. General bipolar/antidepressant warnings not substituted for exact diagnosis/drug.
Factors that may matter: Exact preparation and amount; Other medicines; Seizure history, alertness or electrolyte status where relevant.
Read the supporting source summaries
Source 1: Current U.S. regulatory product labeling
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed oral perphenazine.
May cause initial drowsiness although hypnotic effects are described as minimal. Photosensitivity and anticholinergic effects are possible. Pharmacokinetics covary with CYP2D6 activity.
How this applies: Exact ingredient and oral-route clinical context.
Label class warnings do not establish every exact botanical interaction, event rate or protective supplement interval.
Source 2: Original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Eighteen people with chronic schizophrenia and a low-activity COMT polymorphism.
Some aggression and quality-of-life measures improved, but two SAMe recipients developed increased irritability.
How this applies: Mixed clinical outcomes justify individualized review, not a blanket exact-drug toxicity assertion.
Small selected pilot; inspected abstract does not resolve exact perphenazine co-use or support a pair-specific serotonin-syndrome rate.
Source 3: Federal supplement guidance
nccih.nih.gov · Source check Sep 10, 2026
Population: People considering SAMe.
Warns about possible mania or worsening symptoms in bipolar disorder and interactions with serotonergic medicines.
How this applies: General clinical context for product and psychiatric-treatment review.
Bipolar diagnosis and serotonergic antidepressants cannot automatically be substituted for schizophrenia or perphenazine.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Initial source-checked draft with exact preparation limits, original study findings and uncertainty. Clinical review not recorded. | |
| Research summary published |
Article revision: 25bc01144f0879a5
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.